ACE and cardiovascular disorder: Hasvold et al. found a similar risk of cardiovascular disease in patients being treated with the ACE-inhibitor enalapril and the ARB candesartan [7], while Bönner et al. compared ramipril with AZL-M and also found no significant variations in the occurrence of AEs between the two groups, although they reported a slightly higher occurrence of cough and lower incidences of back pain and dizziness in the ramipril patients [13].